VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 66 filers reported holding VINCERX PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,927 | -56.8% | 57,353 | -44.4% | 0.04% | -61.8% |
| Q2 2023 | $134,030 | -63.5% | 103,100 | -70.8% | 0.11% | -65.6% |
| Q1 2023 | $367,536 | -27.9% | 353,400 | -29.3% | 0.32% | -28.4% |
| Q4 2022 | $510,000 | -26.9% | 500,000 | -1.1% | 0.45% | -49.3% |
| Q3 2022 | $698,000 | +5.6% | 505,559 | +1.0% | 0.88% | +95.8% |
| Q2 2022 | $661,000 | -49.5% | 500,559 | +53.0% | 0.45% | +130.8% |
| Q1 2022 | $1,309,000 | -50.4% | 327,236 | +26.4% | 0.20% | -49.2% |
| Q4 2021 | $2,638,000 | -18.4% | 258,889 | +29.4% | 0.38% | -12.1% |
| Q3 2021 | $3,234,000 | -8.2% | 200,000 | -26.2% | 0.44% | -11.9% |
| Q2 2021 | $3,521,000 | +119.9% | 271,063 | +226.8% | 0.50% | +59.0% |
| Q1 2021 | $1,601,000 | – | 82,948 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,703,413 | $1,720,447 | 0.48% |
| Tejara Capital Ltd | 233,348 | $235,681 | 0.13% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $388,850 | 0.04% |
| SABBY MANAGEMENT, LLC | 57,353 | $57,927 | 0.04% |
| Long Focus Capital Management, LLC | 1,098,753 | $1,109,741 | 0.04% |
| Sio Capital Management, LLC | 102,049 | $103,069 | 0.03% |
| Rock Springs Capital Management LP | 891,719 | $900,636 | 0.02% |
| Rubric Capital Management LP | 354,377 | $357,921 | 0.01% |
| Clearline Capital LP | 98,916 | $99,905 | 0.01% |
| ExodusPoint Capital Management, LP | 389,512 | $393 | 0.00% |